No later than December 31 of each year, the Prescription Drug Affordability Board shall report to the Health Care Cost Growth Target program established in ORS § 442.386 and to the interim committees of the Legislative Assembly related to health, in the manner provided in ORS § 192.245, the following information:

Ask a business law question, get an answer ASAP!
Thousands of highly rated, verified business lawyers.
Click here to chat with a lawyer about your rights.

(1) Price trends for the list of prescription drugs provided to the board by the Department of Consumer and Business Services under ORS § 646A.694 (1);

(2) The prescription drugs that were reviewed under ORS § 646A.694 (1); and

(3) Recommendations, if any, for legislative changes necessary to make prescription drug products more affordable in this state. [2021 c.598 § 5]